Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19: a scoping review

ConclusionThis review suggests the most active substance from each class of metabolites, which presented the strongest affinity to the ACE-II receptor, what contributes as a basis for choosing compounds and directing the further experimental and clinical investigation on the applications these compounds in biotechnological and health processes as in COVID-19 pandemic.
Source: Inflammation Research - Category: Research Source Type: research